Publications

Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

 43
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

Tags:

Previous Article

ERK1/2 signaling targeting in cancer

Next Article

MAPK inhibition to protect against spinal muscular atrophy

Related Posts

Human stem cell-derived GABAergic interneuron development reveals early emergence of subtype diversity and gradual electrochemical maturation

Human stem cell-derived GABAergic interneuron developme...

 82

Neuronal autophagy in the control of synapse function

Neuronal autophagy in the control of synapse function

 91

The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis

The multiple roles of chronic stress and glucocorticoid...

 74